Endo Pharma ends collaboration on back pain drug BusinessWeek Endo Pharmaceuticals Holdings Inc. said Wednesday that it is ending a partnership on an experimental back pain drug. Read more »
Newron Pharma’s neuropathic pain drug fails in Serena study on NLBP patients – pharmabiz.com
Newron Pharma's neuropathic pain drug fails in Serena study on NLBP patients pharmabiz.com ... in patients with at least moderate Neuropathic Low Back Pain (NLBP) failed to show any significant difference between ralfinamide and placebo. Read more »
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin (PRWeb via Yahoo! News)
Nutra Pharma has announced that its over-the-counter (OTC) pain reliever, Cobroxin, has generated sales totaling $583,955 for the fourth quarter ending December 31, 2009. Read more »
